Introduction: The FDA Regulatory Pathway for Peptide-Oligonucleotide Conjugates is not determined simply by identifying a product as either a peptide … Continue reading What FDA Regulatory Pathway Applies to Peptide-Oligonucleotide Conjugate Therapeutics?